NuVasive Clinical Services
The nation’s leading provider of intraoperative neuromonitoring services to surgeons and healthcare facilities.
The nation’s leading provider of intraoperative neuromonitoring services to surgeons and healthcare facilities.
NuVasive is the nation’s leading provider of intraoperative neuromonitoring services to surgeons and healthcare facilities. Founded in 1997, the company is committed to offering a best-in-class IOM experience, serving over 100,000 cases annually. NuVasive combines industry-leading technology, service, and quality in the biotechnology, health care, and medical devices industries. Last investment of $40.46M in post-IPO equity was made on 19 October 2011. The company is headquartered in the United States. With a team of board-certified neurologists and neurophysiologists, NuVasive aims to provide the highest-quality intraoperative neuromonitoring service possible, supported by an industry-leading training and educational program. This demonstrates a commitment to excellence and ongoing growth potential in the healthcare and biotechnology sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $40.46M | - | 19 Oct 2011 | |
| Venture Round | $9.80M | 5 |
|
13 May 2004 |
| Venture Round | $15.00M | - | 01 Jun 2002 |
No recent news or press coverage available for NuVasive Clinical Services.
We care about your data, and we'd love to use cookies make your experience better.
